| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 09/10/2026 | ±3.4% | -1.0% | over-priced |
| 06/09/2026 | ±9.0% | -1.1% | over-priced |
| 03/11/2026 | ±4.8% | -0.3% | over-priced |
| 12/18/2025 | ±8.1% | +1.2% | over-priced |
| 09/10/2025 | ±5.9% | +9.8% | under-priced |
| 06/11/2025 | ±3.3% | +3.4% | under-priced |
| 03/12/2025 | ±6.6% | +2.2% | over-priced |
| 12/20/2024 | ±11.3% | +1.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $2.68 | $29.6B | $13.1B |
| Q2 FY2026 | $1.91 | $22.2B | $9.3B |
| Q1 FY2026 | $1.50 | $19.3B | $7.3B |
| Q4 FY2025 | — | $18.0B | $8.5B |
Broadcom Inc. Common Stock (AVGO) reports in 44 days, with the next report estimated for 12/10/2026. Across the last 8 reports, options priced an average ±6.5% earnings move while the stock actually moved 2.5% on average — the market has systematically over-priced AVGO's earnings risk. Fundamentals into the print: EPS up 215.3% year-over-year, revenue up 85.5%. QuantLogix's live 5-factor engine currently reads AVGO as a underweight at 39/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →